News
Nurullah "lhan: Best Of ASCO26 Highlights For Melanoma and Skin Cancers
1+ hour, 32+ min ago (140+ words) Nurullah "lhan, Associate Professor of Medical Oncology/Sancaktepe "ehit Prof. Dr. "lhan Varank Training and Research Hospital, Founder and Head of Medical Oncology Clinic, shared Andrea Boutros's, Assistant Professor at University of Genoa, post on X, adding: "Thoughtful summary Andrea…...
Read News and Stories about National Cnacer Survivors Day Walk 2026 - Oncodaily
9+ hour, 10+ min ago (152+ words) Elizabeth Mittendorf: Profound Honor to Begin My Term as 2026-27 ASCO President Oncology's Greatest Threat: A System in Crisis Roche'Nurix $2. 3 Billion Deal for BTK Degrader Bexobrutideg in Blood Cancers TESAR Trial: Adjuvant Chemo RT vs Completion TME After Local Excision for…...
Australian and New Zealand Society of Palliative Medicine Conference (ANZSPM 2026) - Oncology News, Insights, Stories by Onco Daily
2+ hour, 48+ min ago (165+ words) Elizabeth Mittendorf: Profound Honor to Begin My Term as 2026-27 ASCO President Oncology's Greatest Threat: A System in Crisis Roche'Nurix $2. 3 Billion Deal for BTK Degrader Bexobrutideg in Blood Cancers 15 Posts Not To Miss From ASCO 2026: Breast Edition ESMO Updates Metastatic Breast…...
City Cancer Challenge (C/Can) is Looking for New Directors - Onco Daily
2+ hour, 46+ min ago (99+ words) City Cancer Challenge (C/Can) shared a post on Linked In: "Cancer doesn't affect everyone equally. Access to diagnosis, treatment, and care depends far too much on where you live. C/Can works with cities to change that, and our…...
Jan "koda: Poster Presentations at EACR 2026 in Budapest
3+ hour, 18+ min ago (119+ words) Jan "koda, Senior Research Team Leader at Fakultn" nemocnice u sv. Anny v Brn" (FNUSA) " St. Anne's University Hospital Brno / FNUSA-ICRC, Associate Professor and Head of Research Group at Masaryk University, shared a post on Linked In: "Are you heading…...
Case of a 62-Year-Old Woman With HER2+/HR" Breast Cancer - Dana-Farber's Breast Oncology Center - Onco Daily
4+ hour, 2+ min ago (102+ words) Dana-Farber's Breast Oncology Center shared a post on X: "Drs. Ada Waks and Sarah Sammons introduce a patient case of a 62yearold woman with HER2+/HR- breast cancer. They discuss how to select an optimal firstline regimen for her amid an expanding range…...
PRODIGE 61 FUNGEMAX: Sequential Chemotherapy in First-Line Metastatic Pancreatic Cancer - Onco Daily
5+ hour, 34+ min ago (1093+ words) Patients with metastatic pancreatic ductal adenocarcinoma continue to have poor outcomes despite the use of combination chemotherapy. In the first-line setting, treatment aims not only to control disease but also to preserve quality of life, as cumulative toxicity and treatment…...
Miguel Mart'n: Addressing the Rising Burden of Breast Cancer in Young Women Through Research - Onco Daily
6+ hour, 35+ min ago (98+ words) Miguel Mart'n: Addressing the Rising Burden of Breast Cancer in Young Women Through Research Oncodaily Miguel Mart'n: Addressing the Rising Burden of Breast Cancer in Young Women Through Research Miguel Mart'n, Emeritus Professor of Medicine at Universidad Complutense, Madrid, shared…...
Read News and Stories about ESTS Women in General Thoracic Surgery - Oncodaily
9+ hour, 12+ min ago (151+ words) Elizabeth Mittendorf: Profound Honor to Begin My Term as 2026-27 ASCO President Oncology's Greatest Threat: A System in Crisis Roche'Nurix $2. 3 Billion Deal for BTK Degrader Bexobrutideg in Blood Cancers 15 Posts Not To Miss From ASCO 2026: Breast Edition Rethinking Care Beyond Cure…...
Rachel Conyers: Uncharted Gap in Neurodiversity and Chemotherapy Toxicity in Pediatric Oncology - Onco Daily
7+ hour, 30+ min ago (139+ words) Rachel Conyers, paediatric oncologist, Director of Children's Cancer Centre at the The Royal Children's Hospital and Professor at the University of Melbourne, shared a post on linked In: "Here's a question nobody in paediatric oncology is asking loudly enough: The…...